Kenvue Inc. $KVUE is Independent Franchise Partners LLP’s 4th Largest Position

Independent Franchise Partners LLP raised its holdings in Kenvue Inc. (NYSE:KVUE) by 56.3% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 48,146,476 shares of the company’s stock after acquiring an additional 17,343,785 shares during the quarter. Kenvue makes up about 5.3% of Independent Franchise Partners LLP’s holdings, making the stock its 4th largest holding. Independent Franchise Partners LLP’s holdings in Kenvue were worth $830,527,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Elyxium Wealth LLC acquired a new stake in shares of Kenvue during the fourth quarter worth about $26,000. Physician Wealth Advisors Inc. lifted its holdings in shares of Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after purchasing an additional 618 shares during the period. SBI Securities Co. Ltd. lifted its holdings in shares of Kenvue by 82.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock worth $39,000 after purchasing an additional 1,027 shares during the period. Leonteq Securities AG acquired a new stake in shares of Kenvue during the fourth quarter worth about $45,000. Finally, DV Equities LLC acquired a new stake in shares of Kenvue during the fourth quarter worth about $46,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Canaccord Genuity Group lifted their target price on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. Barclays decreased their target price on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Tuesday, April 14th. Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday. Citigroup decreased their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Finally, Argus raised Kenvue to a “hold” rating in a report on Friday, March 6th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $19.33.

Kenvue Stock Down 2.2%

Shares of KVUE stock opened at $18.03 on Thursday. The stock has a 50 day moving average of $17.49 and a 200 day moving average of $17.56. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The stock has a market cap of $34.61 billion, a P/E ratio of 21.21, a P/E/G ratio of 1.40 and a beta of 0.54. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $22.87.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. The business had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The business’s revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.24 earnings per share. As a group, sell-side analysts expect that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were given a $0.2075 dividend. The ex-dividend date was Wednesday, May 13th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.6%. Kenvue’s payout ratio is 97.65%.

Insider Activity at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.59% of the stock is owned by company insiders.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.